-
Large observational study finds correlation between prenatal cholesterol-disrupting meds and higher autism rates; causation not proven.
Medical Mythbusting Commentary for April 21, 2026 Source:Millions of US birth records uncover an autism risk surge tied to common drugs taken during pregnancy Reference:Sterol pathway disruption in pregnancy: a link to autism
-
Scientists finally crack mystery of rare COVID adenovirus vaccine blood clots
Medical Mythbusting Commentary for April 15, 2026 Source:Scientists finally crack mystery of rare COVID vaccine blood clots Reference:Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
-
Metformin shown to increase a biological effect of exercise in men with prostate cancer reducing insulin resistance, easing metabolic stress and weight gain. What this isn’t is exercise in a pill.
Medical Mythbusting Commentary for April 14, 2026 Source:Exercise in a Pill? Metformin Shows Surprising Effects in Cancer Patients Reference:The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients
-
After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be for stable low-risk post-MI patients
Medical Mythbusting Commentary for March 31, 2026 Source:After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be
-
The reason Vitamin K1 is given to newborns and why it has been a standard of care for over 65 years.
Medical Mythbusting Commentary for March 26, 2026 Source:It’s not just vaccines: Parents are refusing other routine preventive care for newborns
-
It stands to reason that most medications designed to manage progressive chronic disease once discontinued will see a relapse or progression of said disease process.
Medical Mythbusting Commentary for March 25, 2026 Source:Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds Reference:GLP-1RA discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: A target emulation trial.
-
Limited power study with negligible clinical significant reports low doses of lithium may slow verbal memory decline from Alzheimer’s
Medical Mythbusting Commentary for March 10, 2026 Source:Low doses of lithium may slow verbal memory decline from Alzheimer’s Reference:Low-Dose Lithium for Mild Cognitive Impairment: A Pilot Randomized Clinical Trial
-
What is the evidence that GLP-1 medications such as Ozempic and Mounjaro might help treat addiction?
Medical Mythbusting Commentary for March 9, 2026 Source:What to know about how GLP-1 medications such as Ozempic and Mounjaro might fight addiction Reference:Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
-
The time of day when a dose of immunochemotherapy is given in non-small cell lung cancer may have an impact on treatment efficacy.
Medical Mythbusting Commentary for February 17, 2026 Source:How well a cancer treatment works may depend on the time of day you get it Reference:Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial